Clinical trial
Modafinil to Treat Fatigue in Post-Polio Syndrome
NCT00067496 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Terminated
Key facts
| NCT number | NCT00067496 |
|---|---|
| Title | Modafinil to Treat Fatigue in Post-Polio Syndrome |
| Official title | Modafinil in the Treatment of Fatigue in Post-Polio Syndrome |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Postpoliomyelitis Syndrome |
| Intervention type | Drug |
| Interventions | Modafinil |
| Enrollment | 30 |
| Start date | Aug 1, 2003 |
| Completion | Aug 1, 2006 |
| First posted | Aug 21, 2003 |
| Last update posted | Aug 27, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: